YARW · Yarrow Bioscience, Inc.
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-07-27 | Ashiya Mona |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
This option represents a right to purchase 15,435 shares of the Issuer's common stock, which vests in full on the earlier of (i) July 27, 2027 or (ii) the date of the next annual meeting of the Issuer's stockholders, in each case, subject to the recipient's continued service to the Issuer. Pursuant to an agreement with OrbiMed Advisors LLC, the Reporting Person is obligated to transfer any securities issued under any such stock options or other awards, or the economic benefit thereof, to OrbiMed Advisors LLC, which will in turn ensure that such securities or economic benefits are provided to OrbiMed Private Investments X, LP. |
Stock Option (Right to Buy)
|
15,435 |
| 2026-07-27 | Zeronda Tyler |
CHIEF FINANCIAL OFFICER |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
This option represents a right to purchase 185,798 shares of the Issuer's common stock, one quarter of which will vest on July 27, 2027, with the remaining three quarters vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer on each such vesting date. |
Stock Option (Right to Buy)
|
185,798 |
| 2026-07-23 | Stuart Iain |
CHIEF SCIENTIFIC OFFICER |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. |
Common Stock
|
15,405 |
| 2026-07-23 | Domzalski David |
Director, PRESIDENT AND CEO |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. |
Common Stock
|
79,391 |
| 2026-07-23 | Zeronda Tyler |
CHIEF FINANCIAL OFFICER |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. |
Common Stock
|
22,516 |
| 2026-07-23 | Harsch Mutya |
CHIEF LEGAL OFFICER AND GC |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. |
Common Stock
|
22,516 |
| 2026-06-30 | Harsch Mutya |
CHIEF LEGAL OFFICER AND GC |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. |
Common Stock
|
3,464 |
| 2026-06-30 | Zeronda Tyler |
CHIEF FINANCIAL OFFICER |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. |
Common Stock
|
3,464 |
| 2026-06-30 | Domzalski David |
Director, PRESIDENT AND CEO |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. |
Common Stock
|
12,214 |
| 2026-06-30 | Stuart Iain |
CHIEF SCIENTIFIC OFFICER |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. |
Common Stock
|
2,370 |
| 2026-05-29 | Domzalski David |
Director, PRESIDENT AND CEO |
Award↑
Filing footnotes — Common Stock (Direct)
These shares were acquired under the Issuer's Employee Share Purchase Plan ("ESPP") for the ESPP purchase period beginning on December 1, 2025 and ending on May 31, 2026 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the fair market value closing price of the Issuer's common stock on December 1, 2025 (the first trading day of the offering period). The Reporting Person purchased the maximum number of shares permitted by the terms of the ESPP during the calendar year. |
Common Stock
|
30,791 |
| 2026-03-31 | Zeronda Tyler |
CHIEF FINANCIAL OFFICER |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. |
Common Stock
|
4,007 |
| 2026-03-31 | Stuart Iain |
CHIEF SCIENTIFIC OFFICER |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. |
Common Stock
|
2,876 |
| 2026-03-31 | Harsch Mutya |
CHIEF LEGAL OFFICER AND GC |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. |
Common Stock
|
4,007 |
| 2026-03-31 | Domzalski David |
Director, PRESIDENT AND CEO |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. |
Common Stock
|
14,232 |
| 2025-12-31 | Harsch Mutya |
CHIEF LEGAL OFFICER AND GC |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. |
Common Stock
|
3,579 |
| 2025-12-31 | Domzalski David |
Director, PRESIDENT AND CEO |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. |
Common Stock
|
12,684 |
| 2025-12-31 | Stuart Iain |
CHIEF SCIENTIFIC OFFICER |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. |
Common Stock
|
2,448 |
| 2025-12-31 | Zeronda Tyler |
CHIEF FINANCIAL OFFICER |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. |
Common Stock
|
7,858 |
| 2025-12-12 | Basta Steven L |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
Represents the annual award to non-employee directors of the Issuer, awarded on the date of the Issuer's annual meeting of stockholders. The shares subject to the option vest on December 12, 2026, subject to the Reporting Person's continuous service through such date. |
Stock Option (right to buy)
|
20,000 |
| 2025-12-12 | Little Elisabeth Sandoval |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
Represents the annual award to non-employee directors of the Issuer, awarded on the date of the Issuer's annual meeting of stockholders. The shares subject to the option vest on December 12, 2026, subject to the Reporting Person's continuous service through such date. |
Stock Option (right to buy)
|
20,000 |
| 2025-12-12 | BARBARI SHARON |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
Represents the annual award to non-employee directors of the Issuer, awarded on the date of the Issuer's annual meeting of stockholders. The shares subject to the option vest on December 12, 2026, subject to the Reporting Person's continuous service through such date. |
Stock Option (right to buy)
|
20,000 |
| 2025-12-12 | LEPORE PATRICK G |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
Represents the annual award to non-employee directors of the Issuer, awarded on the date of the Issuer's annual meeting of stockholders. The shares subject to the option vest on December 12, 2026, subject to the Reporting Person's continuous service through such date. |
Stock Option (right to buy)
|
20,000 |
| 2025-09-30 | Zeronda Tyler |
CHIEF FINANCIAL OFFICER |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. |
Common Stock
|
3,420 |
| 2025-09-30 | Domzalski David |
Director, PRESIDENT AND CEO |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. |
Common Stock
|
12,676 |
| 2025-09-30 | Stuart Iain |
CHIEF SCIENTIFIC OFFICER |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. |
Common Stock
|
2,453 |
| 2025-09-30 | Harsch Mutya |
CHIEF LEGAL OFFICER AND GC |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. |
Common Stock
|
3,581 |
| 2025-06-30 | Domzalski David |
Director, PRESIDENT AND CEO |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. |
Common Stock
|
12,676 |
| 2025-06-30 | Zeronda Tyler |
CHIEF FINANCIAL OFFICER |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. |
Common Stock
|
3,420 |
| 2025-06-30 | Stuart Iain |
CHIEF SCIENTIFIC OFFICER |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. |
Common Stock
|
2,453 |
| 2025-06-30 | Harsch Mutya |
CHIEF LEGAL OFFICER AND GC |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. |
Common Stock
|
3,581 |
| 2025-06-02 | Harsch Mutya |
CHIEF LEGAL OFFICER AND GC |
Award↑
Filing footnotes — Common Stock (Direct)
These shares were acquired under the Issuer's Employee Share Purchase Plan ("ESPP") for the ESPP purchase period beginning on December 1, 2024 and ending on May 31, 2025 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the fair market value closing price of the Issuer's common stock on May 30, 2025 (the last trading day of the offering period). |
Common Stock
|
1,145 |
| 2025-06-02 | Domzalski David |
Director, PRESIDENT AND CEO |
Award↑
Filing footnotes — Common Stock (Direct)
These shares were acquired under the Issuer's Employee Share Purchase Plan ("ESPP") for the ESPP purchase period beginning on December 1, 2024 and ending on May 31, 2025 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the fair market value closing price of the Issuer's common stock on May 30, 2025 (the last trading day of the offering period). The Reporting Person purchased the maximum number of shares permitted by the terms of the ESPP during the calendar year. |
Common Stock
|
8,681 |
| 2025-03-31 | Domzalski David |
Director, PRESIDENT AND CEO |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. |
Common Stock
|
30,498 |
| 2025-03-31 | Stuart Iain |
CHIEF SCIENTIFIC OFFICER |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. |
Common Stock
|
6,044 |
| 2025-03-31 | Zeronda Tyler |
CHIEF FINANCIAL OFFICER |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. |
Common Stock
|
8,399 |
| 2025-03-31 | Harsch Mutya |
CHIEF LEGAL OFFICER AND GC |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. |
Common Stock
|
8,828 |
| 2025-01-21 | Harsch Mutya |
CHIEF LEGAL OFFICER AND GC |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The shares subject to the option vest over a period of 4 years. 25% of the shares subject to the option will vest on March 31, 2026 and 6.25% of the shares will vest on the last day of each quarter thereafter. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date. |
Stock Option (right to buy)
|
230,000 |
| 2025-01-21 | Zeronda Tyler |
CHIEF FINANCIAL OFFICER |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The shares subject to the option vest over a period of 4 years. 25% of the shares subject to the option will vest on March 31, 2026 and 6.25% of the shares will vest on the last day of each quarter thereafter. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date. |
Stock Option (right to buy)
|
230,000 |
| 2025-01-21 | Domzalski David |
Director, PRESIDENT AND CEO |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The shares subject to the option vest over a period of 4 years. 25% of the shares subject to the option will vest on March 31, 2026 and 6.25% of the shares will vest on the last day of each quarter thereafter. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date. |
Stock Option (right to buy)
|
730,000 |
| 2025-01-21 | Stuart Iain |
CHIEF SCIENTIFIC OFFICER |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The shares subject to the option vest over a period of 4 years. 25% of the shares subject to the option will vest on March 31, 2026 and 6.25% of the shares will vest on the last day of each quarter thereafter. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date. |
Stock Option (right to buy)
|
230,000 |
| 2025-01-15 | LEPORE PATRICK G |
Director |
Buy↑
Filing footnotes — Common Stock (Direct)
The price reported is a weighted average purchase price. The shares were purchased in multiple transactions at prices ranging from $2.8776 to $2.9836, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. |
Common Stock
|
15,000 |
| 2024-12-31 | Stuart Iain |
CHIEF SCIENTIFIC OFFICER |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. |
Common Stock
|
4,857 |
| 2024-12-31 | Domzalski David |
Director, PRESIDENT AND CEO |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. |
Common Stock
|
24,536 |
| 2024-12-31 | Zeronda Tyler |
CHIEF FINANCIAL OFFICER |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. |
Common Stock
|
4,675 |
| 2024-12-31 | Harsch Mutya |
CHIEF LEGAL OFFICER AND GC |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. |
Common Stock
|
4,697 |
| 2024-12-12 | Basta Steven L |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
Represents the annual award to non-employee directors of the Issuer, awarded on the date of the Issuer's annual meeting of stockholders. The shares subject to the option vest on December 12, 2025, subject to the Reporting Person's continuous service through such date. |
Stock Option (right to buy)
|
20,000 |
| 2024-12-12 | Borowski Christine |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
Represents the annual award to non-employee directors of the Issuer, awarded on the date of the Issuer's annual meeting of stockholders. The shares subject to the option vest on December 12, 2025, subject to the Reporting Person's continuous service through such date. |
Stock Option (right to buy)
|
20,000 |
| 2024-12-12 | Bruno Anthony D |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
Represents the annual award to non-employee directors of the Issuer, awarded on the date of the Issuer's annual meeting of stockholders. The shares subject to the option vest on December 12, 2025, subject to the Reporting Person's continuous service through such date. |
Stock Option (right to buy)
|
20,000 |
| 2024-12-12 | BARBARI SHARON |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
Represents the annual award to non-employee directors of the Issuer, awarded on the date of the Issuer's annual meeting of stockholders. The shares subject to the option vest on December 12, 2025, subject to the Reporting Person's continuous service through such date. |
Stock Option (right to buy)
|
20,000 |